Works by Filiberto, D. M.

Results: 1
    1

    Does the 1:1:1 Transfusion Ratio Mortality Benefit Hold True in Ultra-massive Transfusion? A Study From the Product (Patient Related Outcomes During Ultra-massive transfusion multi-Center Trial) Consortium.

    Published in:
    American Surgeon, 2025, v. 91, n. 9, p. 1484, doi. 10.1177/00031348251358431
    By:
    • Meyer, C. H.;
    • Grady, Z.;
    • Smith, R. N.;
    • Moran, T. P.;
    • Rowh, M.;
    • Zhang, A.;
    • Harfouche, M. N.;
    • Greiffenstein, P.;
    • Trinh, S.;
    • Inaba, K.;
    • Nekooei, N.;
    • Filiberto, D. M.;
    • Jones Sayyid, C. E.;
    • Gutierrez, A.;
    • Meizoso, J.;
    • Risinger, W. B.;
    • Smith, J. W.;
    • Jacovides, C. L.;
    • Trausch, E. D.;
    • McNickle, A. G.
    Publication type:
    Article